Eye Journal
Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization associated with a dome-shaped macula in pathologic myopia – (Eye 31, 507 (March 2017))
Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization associated with a dome-shaped macula in pathologic myopia Eye 31, 507 (March 2017). doi:10.1038/eye.2016.249 Authors: J H Lee, S C Lee, S Choi, H J Koh, S S Kim & C S Lee
Comparison of vision-related quality of life in primary open-angle glaucoma and dry-type age-related macular degeneration – (Eye 31, 395 (March 2017))
Comparison of vision-related quality of life in primary open-angle glaucoma and dry-type age-related macular degeneration Eye 31, 395 (March 2017). doi:10.1038/eye.2016.219 Authors: S Karadeniz Ugurlu, A E Kocakaya Altundal & M Altin Ekin
Elbow splinting as a method to increase patching compliance in amblyopia therapy – (Eye 31, 406 (March 2017))
Elbow splinting as a method to increase patching compliance in amblyopia therapy Eye 31, 406 (March 2017). doi:10.1038/eye.2016.222 Authors: K Sabri, B Easterbrook, B Wakeman, V Mehta & R Riyaz
Pneumatic release of focal vitreomacular traction – (Eye 31, 411 (March 2017))
Pneumatic release of focal vitreomacular traction Eye 31, 411 (March 2017). doi:10.1038/eye.2016.231 Authors: M G Claus, E Feron & M Veckeneer
Benchmarks for outcome indicators in pediatric cataract surgery – (Eye 31, 417 (March 2017))
Benchmarks for outcome indicators in pediatric cataract surgery Eye 31, 417 (March 2017). doi:10.1038/eye.2016.240 Authors: B R Nihalani & D K VanderVeen